These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20020225)

  • 1. Simultaneous treatment of unresectable hepatocelluar carcinoma and hepatic artery aneurysm, case report.
    Hashim M; Salem AA
    J Gastrointest Cancer; 2010 Mar; 41(1):13-6. PubMed ID: 20020225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
    Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
    AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma.
    Seong J; Keum KC; Han KH; Lee DY; Lee JT; Chon CY; Moon YM; Suh CO; Kim GE
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):393-7. PubMed ID: 10030267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embolization of the hepatic falciform artery to prevent supraumbilical skin rash during transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Ueno K; Miyazono N; Inoue H; Miyake S; Nishida H; Nakajo M
    Cardiovasc Intervent Radiol; 1995; 18(3):183-5. PubMed ID: 7648596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
    Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
    Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Unusual Complication of Transarterial Chemoembolization of Hepatocellular Carcinoma; Pseudoaneurysm: A Case Report.
    Atay M; Ozdemir H
    Curr Med Imaging; 2022; 18(11):1244-1247. PubMed ID: 35339188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of metastatic hepatocellular carcinoma of the rib, treated by transcatheter arterial chemoembolization].
    Jung YK; Yeon JE; Kim CH; Lee HJ; Lee YS; Yoon EL; Suck JE; Choi JH; Kim JH; Byun KS
    Korean J Hepatol; 2009 Sep; 15(3):357-61. PubMed ID: 19783885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion.
    Kamada K; Nakanishi T; Kitamoto M; Aikata H; Kawakami Y; Ito K; Asahara T; Kajiyama G
    J Vasc Interv Radiol; 2001 Jul; 12(7):847-54. PubMed ID: 11435541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
    Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
    Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous trans-hepatic gelfoam-cyanoacrylate glue embolization for ruptured post-traumatic hepatic artery pseudo-aneurysm in a limited-resource scenario.
    Kumar M; Goel P; Rawat JD; Kumari S; Shankhwar SN; Kureel SN
    Pediatr Surg Int; 2013 May; 29(5):465-9. PubMed ID: 23479328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-I: hepatic arterial embolization and embolization-based therapies in unresectable hepatocellular carcinoma.
    Reidy DL; Schwartz JD
    Anticancer Drugs; 2004 Jun; 15(5):427-37. PubMed ID: 15166616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of arterial phase CT for prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: a retrospective analysis.
    Katyal S; Oliver JH; Peterson MS; Chang PJ; Baron RL; Carr BI
    AJR Am J Roentgenol; 2000 Dec; 175(6):1665-72. PubMed ID: 11090401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma.
    Schwartz JD; Beutler AS
    Anticancer Drugs; 2004 Jun; 15(5):439-52. PubMed ID: 15166617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
    Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
    J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Chemoembolization of Caudate Lobe Hepatocellular Carcinoma: Anatomy and Procedural Techniques.
    Kim HC; Miyayama S; Chung JW
    Radiographics; 2019; 39(1):289-302. PubMed ID: 30620696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter arterial embolization in unresectable hepatocellular carcinoma.
    Yamada R; Kishi K; Sonomura T; Tsuda M; Nomura S; Satoh M
    Cardiovasc Intervent Radiol; 1990; 13(3):135-9. PubMed ID: 2171771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
    Kodama K; Kawaoka T; Aikata H; Uchikawa S; Inagaki Y; Hatooka M; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Masaki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Chayama K
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1780-1786. PubMed ID: 29645345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of Intraprocedural Transluminal Hepatic and Femoral Artery Blood Pressure Measurements as an Alternative Embolization Safety Endpoint When Antireflux Devices Are Used During Lobar Chemoembolization.
    Rose SC; Kikolski SG; Morshedi MM; Narsinh KH
    AJR Am J Roentgenol; 2015 Jul; 205(1):196-202. PubMed ID: 26102399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic chemoembolization in unresectable pediatric liver malignancies.
    Arcement CM; Towbin RB; Meza MP; Gerber DA; Kaye RD; Mazariegos GV; Carr BI; Reyes J
    Pediatr Radiol; 2000 Nov; 30(11):779-85. PubMed ID: 11100496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supplemental transcatheter arterial chemoembolization through a collateral omental artery: treatment for hepatocellular carcinoma.
    Won JY; Lee DY; Lee JT; Park SI; Kim MJ; Yoo HS; Suh SH; Park SJ
    Cardiovasc Intervent Radiol; 2003; 26(2):136-40. PubMed ID: 12638036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.